Pharmacokinetic (PK) Characterization of Subcutaneous Tulisokibart (MK-7240-010)

NCT06575595 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

BIOLOGICAL: Tulisokibart

Sponsor

Merck Sharp & Dohme LLC